Bio-Rad Labs Inc. A Stock
Bio-Rad Labs Inc. A Stock
The price for the Bio-Rad Labs Inc. A stock decreased slightly today. Compared to yesterday there is a change of -€1.600 (-0.660%).
Currently there is a rather positive sentiment for Bio-Rad Labs Inc. A with 5 Buy predictions and 0 Sell predictions.
As a result the target price of 334 € shows a positive potential of 38.94% compared to the current price of 240.4 € for Bio-Rad Labs Inc. A.
For the coming years our community has positive and negative things to say abot the Bio-Rad Labs Inc. A stock. Criterium "Revenue growth" gathered the most positive votes but regarding "Revenue growth" there were negative voices in the community.
Pros and Cons of Bio-Rad Labs Inc. A in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
S********** s********
Cons
?
M***** P*******
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bio-Rad Labs Inc. A vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bio-Rad Labs Inc. A | -0.660% | 2.341% | 0.460% | 6.278% | -6.786% | -44.455% | -50.535% |
| Neogen Corp. | 1.920% | 1.258% | -15.707% | 1.258% | 30.894% | - | - |
| Haemonetics Corp. | 0.820% | -5.000% | -10.182% | - | -27.883% | - | - |
| CONMED Corp. | -1.960% | -5.063% | -23.077% | -44.954% | -14.286% | -68.085% | -72.973% |
Comments
Bio-Rad Laboratories (NYSE:BIO) had its price target raised by analysts at Citigroup Inc. from $350.00 to $375.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BIO provided by MarketBeat
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target raised by analysts at Royal Bank Of Canada from $387.00 to $409.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for BIO provided by MarketBeat
Bio-Rad Laboratories, Inc. (NYSE: BIO) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for BIO provided by MarketBeat